new indications for glp-1 drugs Molecules and Emerging Medicines Color coding GLP-1 drugs likely to be

It is also too early to know what impact quitting has on long-term health (Youmshajekian) Acknowledgements This piece was originally published in April 2025 by Lara Marks with the generous help of Svetlana Mojsov, Jens Holst and Richard Ng who read early drafts

One honest caveat from the data: because the Phase 2 curve had not clearly plateaued by the end of the study, the full ceiling of the effect is genuinely not yet known that is one of the questions the Phase 3 TRIUMPH program is designed to answer

One medication of growing interest to our patients is Ozempic, which contains the active ingredient semaglutide

[DOI] [PMC free article] [PubMed] [Google Scholar] 35.Baig MU, et al